Literature DB >> 25573607

Neuroendocrine Merkel cell nodal carcinoma of unknown primary site: management and outcomes of a rare entity.

E A Kotteas1, N Pavlidis2.   

Abstract

Merkel cell nodal carcinoma of unknown primary (MCCUP) is a rare neuroendocrine tumour with distinct clinical and biological behaviour. We conducted a review of retrospective data extracted from 90 patients focusing on the management and outcome of this disease. We also compared life expectancy of these patients with the outcome of patients with known Merkel primaries and with neuroendocrine cancers of unidentifiable primary. There is a limited body of data for this type of malignancy, however, patients with Merkel cell nodal carcinoma of unknown primary site, seem to have better survival when treated aggressively than patients with cutaneous Merkel tumours of the same stage and equal survival with patients with low-grade neuroendocrine tumour of unknown origin. The lack of prospective trials, and the inadequate data, hamper the management of these tumours. Establishment of treatment guidelines is urgently needed.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Merkel carcinoma; Unknown primary

Mesh:

Year:  2014        PMID: 25573607     DOI: 10.1016/j.critrevonc.2014.12.005

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  8 in total

1.  Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel.

Authors:  Francesca Spada; Paolo Bossi; Corrado Caracò; Vanna Chiarion Sileni; Angelo Paolo Dei Tos; Nicola Fazio; Giovanni Grignani; Michele Maio; Pietro Quaglino; Paola Queirolo; Paolo Antonio Ascierto
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

Review 2.  Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy Approaches.

Authors:  Daniela Femia; Natalie Prinzi; Andrea Anichini; Roberta Mortarini; Federico Nichetti; Francesca Corti; Martina Torchio; Giorgia Peverelli; Filippo Pagani; Andrea Maurichi; Ilaria Mattavelli; Massimo Milione; Nice Bedini; Ambra Corti; Maria Di Bartolomeo; Filippo de Braud; Sara Pusceddu
Journal:  Target Oncol       Date:  2018-10       Impact factor: 4.493

3.  Not Your Typical Tonsil: Metastatic Merkel Cell Carcinoma or Primary Disease?

Authors:  Jason C DeGiovanni; Cathleen C Kuo; Ellen L Tokarz; Ameer T Shah; Miriam OLeary
Journal:  Cureus       Date:  2021-04-21

4.  Merkel Cell Carcinoma Patients Presenting Without a Primary Lesion Have Elevated Markers of Immunity, Higher Tumor Mutation Burden, and Improved Survival.

Authors:  Natalie Vandeven; Christopher W Lewis; Vladimir Makarov; Nadeem Riaz; Kelly G Paulson; Daniel Hippe; Amy Bestick; Ryan Doumani; Tessa Marx; Seesha Takagishi; Timothy A Chan; Jaehyuk Choi; Paul Nghiem
Journal:  Clin Cancer Res       Date:  2017-12-15       Impact factor: 12.531

5.  Merkel cell carcinoma of unknown primary site; case presentation and review of the literature.

Authors:  Elissaios Kontis; Antonios Vezakis; Eirini Pantiora; Sotiria Stasinopoulou; Andreas Polydorou; Dionysios Voros; Georgios P Fragulidis
Journal:  Ann Med Surg (Lond)       Date:  2015-10-26

6.  Unknown primary Merkel cell carcinoma in the immunosuppressed patient: Case series.

Authors:  Jason M Rizzo; Paul W Harms; Kelly L Harms; Andrew Plaska; Chad Brenner; Alison B Durham
Journal:  JAAD Case Rep       Date:  2020-12-01

7.  Nodal Merkel Cell Carcinoma with Unknown Primary Site and No Distant Metastasis: A Single-Center Series.

Authors:  Nicola Fazio; Patrick Maisonneuve; Francesca Spada; Lorenzo Gervaso; Chiara Alessandra Cella; Marta Pozzari; Dario Zerini; Eleonora Pisa; Caterina Fumagalli; Massimo Barberis; Alice Laffi; Chiara Maria Grana C; Gianmarco Orsolini; Pierpaolo Prestianni; Guido Bonomo; Luigi Funicelli; Emilio Bertani; Paola Queirolo; Davide Ravizza; Manila Rubino; Giulio Tosti; Elisabetta Pennacchioli
Journal:  Cancers (Basel)       Date:  2022-09-29       Impact factor: 6.575

8.  18F-FDG and 68Ga-somatostatin analogs PET/CT in patients with Merkel cell carcinoma: a comparison study.

Authors:  Silvia Taralli; Martina Sollini; Michele Milella; Germano Perotti; Angelina Filice; Massimo Menga; Annibale Versari; Vittoria Rufini
Journal:  EJNMMI Res       Date:  2018-07-21       Impact factor: 3.138

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.